Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE tracks Europe higher on trade hopes; Shire shines

Fri, 14th Sep 2018 10:16

(For a live blog on European stocks, type LIVE/ in an Eikonnews window)

* FTSE 100 up 0.1 pct

* Shire gains after China nod to Takeda deal

* Housebuilders under pressure

* Investec rallies on spin-off plans

By Danilo Masoni

MILAN, Sept 14 (Reuters) - Britain's top share index trackedhigher European markets on Friday with the mood buoyed by easingtrade worries, while Shire rose after China cleared Takeda'splans to buy the drugmaker.

The FTSE 100 was up 0.1 percent by 0857 GMT,underpinned by gains among the energy and healthcare sectors,which more than offset weakness among utilities, hit earlierthis week by a profit warning from SSE.

"Traders (are) hopeful about U.S.-China trade talks despitePresident Trump being the fly in the ointment, downplayingprospects for quick negotiations," Accendo Markets analayst Mikevan Dulken said.

Trump said on Thursday that the United States was under nopressure to make a trade deal with China, even as Chineseofficials welcomed an invitation from Washington for a new roundof talks with more U.S. tariffs looming.

The FTSE was set for a small weekly gain following twoconsecutive weeks of losses partly due to a rally in the poundon prospects of a Brexit deal with the European Union.

On Friday the pound rose further, touching its highest levelsince early August. The index, whose constituents make more thantwo-thirds of their sales abroad, shrugged off the latest movein the pound but it remains down 5.3 percent so far in 2018.

Shire rose 1.5 percent.

Takeda Pharmaceutical said China approved itspurchase of Shire, the latest regulator to clear the $62 billiondeal and bring the Japanese group closer to becoming a globaltop 10 drugmaker.

Taked expects the deal to close in the first half of 2019although it needs shareholder approval to raise the funds to payfor the $62 billion deal.

British housebuilders were under pressure after Bank ofEngland governor Mark Carney was reported in The Times as havingtold ministers that a no-deal Brexit could cause house prices tofall by 35 percent over three years.

Barrat Developments and Taylor Wimpey wereboth down around 1 percent, among the top fallers on the FTSE.

Mid-cap Investec rose 8 percent on news it plans tohive off and separately list its asset management unit in arestructuring that comes as the long-serving company founderleaves the financial services group.

"Investec's plan to spin off its asset management arm lookslike a sensible decision as it should allow management morefreedom to drive that business forward and not be constrained byhaving to follow the strategy of the current parent which ispredominantly a specialist banking business," said Russ Mould,investment director at AJ Bell.

JD Wetherspoon declined 0.7 percent after the pubchain said it expected higher costs this year even though arecord heatwave that brought in more customers lifted itsfull-year profit.(Reporting by Danilo MasoniEditing by Mark Heinrich)

More News
30 Nov 2018 07:38

LONDON MARKET PRE-OPEN: Ecolab To Acquire Bioquell For GBP141 Million

LONDON (Alliance News) - Stock prices in London are seen opening marginally lower on Friday as investors await a meeting of US and Chinese leaders at the G20 summit.IG futures indicate the FTSE is

Read more
30 Nov 2018 07:23

Shire gets EC approval for hereditary angioedema jab

(Sharecast News) - Shire's injectable treatment for hereditary angioedema (HAE) has been cleared for launch in European, having enjoyed early success in the US.

Read more
28 Nov 2018 07:53

Shire's Lanadelumab Help Study Meets Primary And Secondary Endpoints

LONDON (Alliance News) - Shire PLC said Tuesday it has published the full results of its phase III Help study of its hereditary angioedema drug Lanadelumab showing that the study met all of its is

Read more
20 Nov 2018 14:34

EU clears Takeda's Shire acquisition on divestment condition

(Sharecast News) - The European Commission has cleared Takeda Pharmaceutical's £46bn acquisition of Shire, subject to the divestment of a bowel disease drug under development by Shire.

Read more
1 Nov 2018 12:48

TOP NEWS: Shire Revenue Climbs On Strong Performance From Immunology

LONDON (Alliance News) - Shire PLC on Thursday updated its guidance and said its revenue grew in the third quarter of of 2018 as a result of strong Immunology division growth, recent product and a

Read more
1 Nov 2018 12:09

Shire sales remain solid, Takeda deal 'on track'

(Sharecast News) - Shire Pharmaceuticals, the subject of a $62bn takeover by Japan's Takeda, said its focus on rare diseases had offset foreign exchange weakness and boosted third-quarter profits.

Read more
1 Nov 2018 08:48

LONDON MARKET OPEN: Oil Stocks And Strong Pound Weigh On FTSE 100

LONDON (Alliance News) - Stocks in London opened mixed on Thursday, with heavyweight oil majors and a stronger pound hampering the FTSE 100, ahead of the Bank of England's interest rate decion

Read more
31 Oct 2018 06:11

Takeda's raises full-year outlook after Q2 profit rise

TOKYO, Oct 31 (Reuters) - Takeda Pharmaceutical Co Ltd on Wednesday raised its annual operating profit outlook to 268.9 billion yen. That compares with an earlier company estimate of yen an

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 12:19

Takeda proposes selling off Shire drug to gain merger clearance

(Sharecast News) - Takeda Pharmaceuticals may need to sell off one of Shire's pipeline drugs in order to gain European regulatory clearance for the agreed $62bn takeover.

Read more
29 Oct 2018 10:51

WINNERS & LOSERS SUMMARY: HSBC Rises After Upbeat Third Quarter

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------HSBC,

Read more
29 Oct 2018 07:35

LONDON MARKET PRE-OPEN: Better-Than-Expected HSBC To Lift FTSE 100

LONDON (Alliance News) - Stocks in London are set to open on firmer ground on Monday, following last week's sell-off, while traders eye Chancellor Philip Hammond's UK government shares in in

Read more
26 Oct 2018 07:52

Takeda Secures JPY1 Trillion Of Financing To Help Shire Deal

LONDON (Alliance News) - Japan's Takeda Pharmaceuticals Inc on Friday said it has secured new financing to help it with its acquisition of FTSE 100 member Shire PLC.The new short-term a

Read more
25 Oct 2018 16:21

Shire hopes to get green light for US Flexbumin manufacture

(Sharecast News) - Shire on Thursday filed a submission to the US food and drug administration to gain approval to manufacture Flexbumin at its new facility in the state of Georgia.

Read more
25 Oct 2018 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 26 October GlencoreQ3 ProductionInternational Consolidated Airlines GroupQ3 Bank 1

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.